Al-Motwee S, Jawdat D, Jehani G, Anazi H, Shubaili A, Sutton P
Ann Saudi Med. 2013; 33(3):229-34.
PMID: 23793423
PMC: 6078530.
DOI: 10.5144/0256-4947.2013.229.
Relle M, Schwarting A
Clin Dev Immunol. 2012; 2012:584374.
PMID: 22761632
PMC: 3385965.
DOI: 10.1155/2012/584374.
Monticielo O, Mucenic T, Xavier R, Tavares Brenol J, Chies J
Clin Rheumatol. 2008; 27(4):413-9.
PMID: 18214570
DOI: 10.1007/s10067-008-0838-8.
Kyttaris V, Katsiari C, Juang Y, Tsokos G
Curr Rheumatol Rep. 2005; 7(6):469-75.
PMID: 16303108
DOI: 10.1007/s11926-005-0054-3.
Singh A
Ann Rheum Dis. 1993; 52(5):378-83.
PMID: 8323386
PMC: 1005053.
DOI: 10.1136/ard.52.5.378.
No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.
Yao Z, Hartung K, Ehrfeld H, Seelig H, Deicher H, Brunnler G
Rheumatol Int. 1993; 13(4):155-8.
PMID: 8310208
DOI: 10.1007/BF00301263.
HLA class II genes and antibodies against recombinant U1-nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group.
Yao Z, Seelig H, Ehrfeld H, Renz M, Hartung K, Deicher H
Rheumatol Int. 1994; 14(2):63-9.
PMID: 7824837
DOI: 10.1007/BF00300249.
Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members.
Halpern R, Davidson A, Lazo A, Solomon G, Lahita R, Diamond B
J Clin Invest. 1985; 76(2):731-6.
PMID: 3875631
PMC: 423889.
DOI: 10.1172/JCI112028.
Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.
Reveille J, Arnett F, Wilson R, Bias W, McLean R
Immunogenetics. 1985; 21(4):299-311.
PMID: 3873410
DOI: 10.1007/BF00430796.
Systemic lupus erythematosus in Ireland: a review of 50 patients.
Thomas M, Bresnihan B
Ir J Med Sci. 1986; 155(1):1-5.
PMID: 3700060
DOI: 10.1007/BF02939942.
Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families.
Alarcon G, Barger B, Go R, Acton R, Schrohenloher R, Koopman W
Rheumatol Int. 1987; 7(2):71-5.
PMID: 3616388
DOI: 10.1007/BF00270310.
Systemic lupus erythematosus clinical issues.
STEVENS M
Springer Semin Immunopathol. 1986; 9(2-3):251-70.
PMID: 3544281
DOI: 10.1007/BF02099025.
Lupus diseases associated with hereditary and acquired deficiencies of complement.
Agnello V
Springer Semin Immunopathol. 1986; 9(2-3):161-78.
PMID: 3544278
DOI: 10.1007/BF02099020.
Organ-specific autoantibodies in non-organ-specific autoimmune diseases with special reference to rheumatoid arthritis.
Youinou P, Mangold W, Jouquan J, Swirsky H, Le Goff P, Scherbaum W
Rheumatol Int. 1987; 7(3):123-6.
PMID: 3499649
DOI: 10.1007/BF00270464.
New approaches to treating systemic lupus erythematosus.
Wofsy D
West J Med. 1987; 147(2):181-6.
PMID: 3310402
PMC: 1025772.
Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins.
Levcovitz H, Fletcher M, Phillips P, Chertok H, Altman R, Benke P
Hum Genet. 1988; 80(3):253-8.
PMID: 3263937
DOI: 10.1007/BF01790093.
Autoimmunity to La (SS-B) in vitro is related to HLA-DR3 in healthy subjects.
Venables P, Rigby S, Mumford P, Markwick J, Maini R
Ann Rheum Dis. 1988; 47(1):22-7.
PMID: 3257861
PMC: 1003438.
DOI: 10.1136/ard.47.1.22.
Evidence that autoimmunity in man is a Mendelian dominant trait.
Bias W, Reveille J, Beaty T, Meyers D, Arnett F
Am J Hum Genet. 1986; 39(5):584-602.
PMID: 3098096
PMC: 1684061.
HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease.
Genth E, Zarnowski H, Mierau R, Wohltmann D, Hartl P
Ann Rheum Dis. 1987; 46(3):189-96.
PMID: 2953314
PMC: 1002098.
DOI: 10.1136/ard.46.3.189.
Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.
Zubler R, Huang Y, MIESCHER P
Springer Semin Immunopathol. 1986; 9(2-3):195-218.
PMID: 2949381
DOI: 10.1007/BF02099022.
